Further analysis revealed that, within the tumor, the LGALS9-CD44 signaling pathway from Macro_SPP1 macrophages to CD8_Tex_C2 T cells was upregulated in the non-responder (NR) group. The gene discussed is LGALS9; the disease is neoplasm.